T2 Biosystems ( (TTOO) ) has released a notification of late filing.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
T2 Biosystems, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for this delay is the company’s inability to allocate financial resources necessary for engaging an independent public accounting firm to audit the financial statements. This situation arose after the company terminated all employees and ceased operations on February 13, 2025, and subsequently engaged an advisory firm to sell its assets. T2 Biosystems has not provided a specific timeline for when the Form 10-K will be filed, as it is uncertain when the necessary financial resources will be available. The company anticipates significant changes in its financial results, but a reasonable estimate cannot be made at this time. The notification includes forward-looking statements regarding the company’s expectations and uncertainties. The notification was signed by John Sprague, Chief Financial Officer, on April 1, 2025.
More about T2 Biosystems
YTD Price Performance: -69.25%
Average Trading Volume: 1,229,333
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.09M
Learn more about TTOO stock on TipRanks’ Stock Analysis page.